Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y L He

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|September 17, 2008
Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetesD Serra, Y-L He, J Bullock, et al.
The Journal of Clinical Endocrinology and Metabolism|May 12, 2005
Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetesA Mari, W M Sallas, Y L He, et al.
Acta Psychiatrica Scandinavica|June 15, 2007
Delay in initial treatment contact after first onset of mental disorders in metropolitan ChinaS Lee, S C Fung, A Tsang, et al.
Psychological Medicine|April 7, 2010
The prevalence of family childhood adversities and their association with first onset of DSM-IV disorders in metropolitan ChinaS Lee, W J Guo, A Tsang, et al.
Biomed Research International|August 12, 2017
Prevalence and Molecular Characterization of Second-Line Drugs Resistance among Multidrug-Resistant <i>Mycobacterium tuberculosis</i> Isolates in Southwest of ChinaY Hu, L Xu, Y L He, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 22, 2006
Evaluation of the pharmacokinetic interaction between fluvastatin XL and cyclosporine in renal transplant recipientsH Holdaas, E Hagen, A Asberg, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|January 9, 2022
[Progress in treatment for malignant pleural mesothelioma]Y Y Wang, Y L He, Y J Chi, et al.
European Review for Medical and Pharmacological Sciences|July 14, 2018
Comparative study between mini-open TLIF via Wiltse's approach and conventional open TLIF in lumbar degenerative diseasesH-J Li, D-W Ge, S Zhang, et al.
Free Radical Research|November 4, 2014
5-HMF prevents against oxidative injury via APE/Ref-1J-H Zhang, Y Di, L-Y Wu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|October 8, 2022
[The effect of maternal HBV DNA levels on HBV intrauterine transmission and fetal distress]J Wang, T T Yan, Y L Feng, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
International Journal of Clinical Pharmacology and Therapeutics|September 17, 2008
Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetesD Serra, Y-L He, J Bullock, et al.
The Journal of Clinical Endocrinology and Metabolism|May 12, 2005
Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetesA Mari, W M Sallas, Y L He, et al.
Acta Psychiatrica Scandinavica|June 15, 2007
Delay in initial treatment contact after first onset of mental disorders in metropolitan ChinaS Lee, S C Fung, A Tsang, et al.
Psychological Medicine|April 7, 2010
The prevalence of family childhood adversities and their association with first onset of DSM-IV disorders in metropolitan ChinaS Lee, W J Guo, A Tsang, et al.
Biomed Research International|August 12, 2017
Prevalence and Molecular Characterization of Second-Line Drugs Resistance among Multidrug-Resistant <i>Mycobacterium tuberculosis</i> Isolates in Southwest of ChinaY Hu, L Xu, Y L He, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 22, 2006
Evaluation of the pharmacokinetic interaction between fluvastatin XL and cyclosporine in renal transplant recipientsH Holdaas, E Hagen, A Asberg, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|January 9, 2022
[Progress in treatment for malignant pleural mesothelioma]Y Y Wang, Y L He, Y J Chi, et al.
European Review for Medical and Pharmacological Sciences|July 14, 2018
Comparative study between mini-open TLIF via Wiltse's approach and conventional open TLIF in lumbar degenerative diseasesH-J Li, D-W Ge, S Zhang, et al.
Free Radical Research|November 4, 2014
5-HMF prevents against oxidative injury via APE/Ref-1J-H Zhang, Y Di, L-Y Wu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|October 8, 2022
[The effect of maternal HBV DNA levels on HBV intrauterine transmission and fetal distress]J Wang, T T Yan, Y L Feng, et al.
Pageof 11